IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3599-3605

  Verbon, A ^a   Dekkers, P E P ^a   Ten Hove, T ^a   Hack, C E ^a   Pribble, J P ^a   Turner, T ^a   Souza, S ^a   Axtelle, T ^a   Hoek, F J ^a   Van Deventer, S J H ^a   Van der Poll, T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD14 ANTIBODY; CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IC14; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL CELL WALL; CELL ACTIVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRANULOCYTE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; INFLAMMATION; INFUSION; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS;

EID: 0035284868     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3599     Document Type: Article

References (46)

1. CD14: Cell surface receptor and differentiation marker
2. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation
3. Binding of bacterial peptidoglycan to CD14
4. CD14 is a pattern recognition receptor
5. Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis
6. Endotoxin opens the Tollgates to innate immunity
7. CD14 and innate recognition of bacteria
8. The pathogenesis of sepsis: Factors that modulate the response to Gram-negative bacterial infection
9. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin
10. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14
11. Antibodies against CD14 protect primates from endotoxin-induced shock
12. 1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis
13. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII
14. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro
15. Presence of bactericidal/permeability-increasing protein in disease: Detection by ELISA
16. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism
17. Phagocytosis of Gram-negative bacteria by a unique CD14-dependent mechanism
18. The pathogenesis of sepsis
19. Pathogenesis and potential strategies for prevention and treatment of septic shock: An update
20. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice
21. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide
22. A lipid A analog. E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia
23. Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: Effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor
24. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration
25. Attenuation of proinflammatory response by recombinant human IL-10, in human endotoxemia: Effect of timing of recombinant human IL-10 administration
26. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia
27. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol
28. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
29. Tissue destruction by neutrophils
30. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipopolysaccharide binding protein and CD14
31. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model
32. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14
33. Increased serum concentration of soluble CD14 is a prognostic marker in Gram-positive sepsis
34. Function of soluble CD14 in serum from patients with septic shock
35. The origin and function of soluble CD14 in experimental bacterial meningitis
36. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome
37. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood
38. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells
39. Activation of human endothelial cells by viable or heat-killed Gram-negative bacteria requires soluble CD14
40. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin
41. Acute-phase proteins and other systemic responses to inflammation
42. The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent
43. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans
44. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans
45. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-α production
46. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis